Rebecca and John Moores UCSD Cancer Center — La Jolla, California

Rebecca and John Moores UCSD Cancer Center is a clinical research site located in La Jolla, California, United States 92093-0658.

Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.

Rebecca and John Moores UCSD Cancer Center has participated in 119 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Kidney Cancer, Unspecified Adult Solid Tumor, Protocol Specific.

Sponsors: Alliance for Clinical Trials in Oncology, Children's Oncology Group, Radiation Therapy Oncology Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in La Jolla

Browse all research sites in California · View every site in La Jolla

Sponsor Feasibility Report

Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rebecca and John Moores UCSD Cancer Center?

Rebecca and John Moores UCSD Cancer Center has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rebecca and John Moores UCSD Cancer Center conducted?

Rebecca and John Moores UCSD Cancer Center has 119 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Kidney Cancer, Unspecified Adult Solid Tumor, Protocol Specific.

Is Rebecca and John Moores UCSD Cancer Center accredited by Crixeo Clinical Trials?

Rebecca and John Moores UCSD Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rebecca and John Moores UCSD Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.